Boehringer Ingelheim KG & Ors v Swingward Ltd

Boehringer Ingelheim KG & Ors v Swingward Ltd

The Court determined that significant uncertainties remain regarding the application of the Bristol-Myers Squibb v Paranova conditions to reboxed and overstickered pharmaceutical products, particularly concerning the burden of proof, the scope of the necessity and reputation conditions, and the assessment of remedies. The Court formulated specific questions for reference to the European Court of Justice to resolve these uncertainties and adjourned the appeals pending the ECJ's answers.

Parties
Appellant/claimant: Boehringer Ingelheim KG; Appellant/claimant: Boehringer Ingelheim Pharma GmbH & Co KG; Appellant/claimant: Boehringer Ingelheim Limited; Appellant/claimant: Glaxo Group Limited; Respondent/claimant: Smithkline Beecham plc; Respondent/claimant: Beecham Group plc; Respondent/claimant: Smithkline and French Laboratories Limited; Respondent/claimant: Eli Lilly and Company; Respondent/defendant: Swingward Limited; Appellant/defendant: Dowelhurst Limited
Jurisdiction
England and Wales
Judgment Date
17 June 2004
Procedural Posture
Civil Appeal / Reference to Ecj; Appeals Adjourned
Outcome
Reference to European Court of Justice; appeals adjourned
Legal Topics
Trade Marks, Parallel Importation, Repackaging of Pharmaceuticals, Burden of Proof, Remedies for Infringement
Intellectual Property Law European Union Law Trade Marks Parallel Importation Repackaging of Pharmaceuticals Burden of Proof Remedies for Infringement

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 4 Authorities cited 5 Party arguments 2 Amounts and remedies 1
Sign in to unlock

Parties

Boehringer Ingelheim KG

Appellant/claimant

Boehringer Ingelheim Pharma GmbH & Co KG

Appellant/claimant

Boehringer Ingelheim Limited

Appellant/claimant

Glaxo Group Limited

Appellant/claimant

Smithkline Beecham plc

Respondent/claimant

Beecham Group plc

Respondent/claimant

Smithkline and French Laboratories Limited

Respondent/claimant

Eli Lilly and Company

Respondent/claimant

Swingward Limited

Respondent/defendant

Dowelhurst Limited

Appellant/defendant

Procedural Posture

Civil Appeal / Reference to Ecj; Appeals Adjourned

Legal Issues

  1. 1 Whether the burden of proof regarding compliance with the Bristol-Myers Squibb v Paranova conditions lies with the importer or trade mark proprietor in cases of reboxing or overstickering pharmaceutical products
  2. 2 Whether the necessity condition applies to the manner and style of reboxing/overstickering or only to the fact of repackaging
  3. 3 Scope of the fourth condition: whether it is limited to defective/untidy packaging or extends to anything damaging the reputation of the trade mark

Ratio Decidendi

The Court determined that significant uncertainties remain regarding the application of the Bristol-Myers Squibb v Paranova conditions to reboxed and overstickered pharmaceutical products, particularly concerning the burden of proof, the scope of the necessity and reputation conditions, and the assessment of remedies. The Court formulated specific questions for reference to the European Court of Justice to resolve these uncertainties and adjourned the appeals pending the ECJ's answers.

Court Disposition

Reference to European Court of Justice; appeals adjourned

Orders

  • Questions referred to the ECJ for preliminary ruling
  • No order as to costs at this stage; costs deferred until after ECJ decision